The Immune Checkpoint Kick Start: Optimization of Neoadjuvant Combination Therapy Using Game Theory

PURPOSE: In an upcoming clinical trial at the Moffitt Cancer Center for women with stage 2/3 estrogen receptor–positive breast cancer, treatment with an aromatase inhibitor and a PD-L1 checkpoint inhibitor combination will be investigated to lower a preoperative endocrine prognostic index (PEPI) tha...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JCO Clin Cancer Inform
Main Authors: West, Jeffrey, Robertson-Tessi, Mark, Luddy, Kimberly, Park, Derek S., Williamson, Drew F.K., Harmon, Cathal, Khong, Hung T., Brown, Joel, Anderson, Alexander R.A.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2019
Assuntos:
ORIGINAL REPORT
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6873943/
https://ncbi.nlm.nih.gov/pubmed/30742484
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/CCI.18.00078
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados